Agilon Health Inc
(NYSE:AGL)
$17.93
-0.18[-0.99%]
Last update: 9:34AM (Delayed 15-Minutes)
Get Real Time Here
$18.11
0.1800[1.00%]
Open-Close-
Vol / Avg.12.985K / 2.281MMkt Cap7.270B
Day Range- - -52 Wk Range15.000 - 29.440

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Agilon Health Stock (NYSE:AGL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$44.00

Lowest Price Target1

$22.00

Consensus Price Target1

$28.87

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
152100

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • TD Cowen
  • Truist Securities
  • Evercore ISI Group
  • RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agilon Health

All Ratings (45)

Upgrades (0)

Downgrades (0)

Initiations (16)

Q

What is the target price for Agilon Health (AGL)?

A

The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agilon Health (AGL)?

A

The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Q

Is the Analyst Rating Agilon Health (AGL) correct?

A

While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.